Omeros1240 Fifth Avenue, Suite 2600Seattle, WA Phone: 206-676-5000 Web site: www.omeros.com
Developing drugs for the treatment of surgery-related inflammation and pain.
Recent IPO Information: Information on recent IPOs is provided by a third party. These securities, which are now trading in the after-markets, are not necessarily available for purchase at ShareBuilder. See the stock quote detail page or the ShareBuilder List to check the status of a particular stock. A link to a copy of the prospectus will be provided to stock purchasers.
IPO Prospectuses: Publication of a prospectus is not a recommendation by ShareBuilder Securities Corporation that any particular investor should purchase the securities described or that the securities are a suitable investment for any particular investor.
IPO Content Provider: IPO content provided by www.RenaissanceCapital.com, the global leader in IPO research.
All quotes are delayed: NYSE and Amex - at least 20 minutes, NASDAQ - 15 minutes. Research Disclosure
Research Disclaimer: Some research material provided by MarketWatch. © MarketWatch, Inc. 2008. All rights reserved. Subject to the Terms of Use. Designed and powered by Dow Jones Client Solutions. MarketWatch, the MarketWatch logo, BigCharts and the BigCharts logo are registered trademarks of MarketWatch, Inc. Dow Jones is the registered trademark of Dow Jones & Company, Inc. Intraday data provided by Interactive Data Real Time Services and subject to the Terms of Use. Intraday data is at least 20-minutes delayed. All times are ET. Historical and current end-of-day data provided by Interactive Data Pricing and Reference Data. The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc., and have been licensed for use.
Securities products are offered by ShareBuilder Securities Corporation, a registered broker-dealer and Member FINRA/SIPC. ShareBuilder Securities Corporation is a subsidiary of ING Bank, fsb. Brokerage Financial Statement